Adjuvant Radiotherapy in Patients With Pathological High-risk Bladder Cancer (GETUG-AFU 30)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
This is a randomized multicentre study in patients with high-risk MIBC to investigate adjuvant radiotherapy after radical cystectomy and pelvic lymph node dissection. The objective of the study is to provide evidence that adjuvant radiotherapy improves loco-regional control with potential benefits in survival. The study will also evaluate the quality of life of patients and the tolerance of the treatment.
Epistemonikos ID: 200d0f7af365f1500223b1b7091dce42cb5f4072
First added on: May 21, 2024